World Health Organization Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, The University of Hong Kong, Hong Kong, China.
World Health Organization Collaborating Centre for Reference and Research, Melbourne, Victoria, Australia.
PLoS One. 2020 Nov 9;15(11):e0241693. doi: 10.1371/journal.pone.0241693. eCollection 2020.
Two lineages of influenza B virus currently co-circulate and have distinct antigenicity, termed Victoria and Yamagata after the B/Victoria/2/87 and B/Yamagata/16/88 strains, respectively. We analyzed antibody titer dynamics following PCR-confirmed influenza B virus infection in a longitudinal community-based cohort study conducted in Hong Kong from 2009-2014 to assess patterns in changes in antibody titers to B/Victoria and B/Yamagata viruses following infections with each lineage. Among 62 PCR-confirmed cases, almost half had undetectable hemagglutination inhibition (HAI) antibody titers to the lineage of infection both pre-infection and post-infection. Among those infected with influenza B/Victoria who showed an HAI titer response after infection, we found strong rises to the lineage of infection, positive but smaller cross-lineage HAI titer boosts, a small dependence of HAI titer boosts on pre-infection titers, and a shorter half-life of HAI titers in adults. Our study is limited by the low HAI sensitivity for non-ether-treated IBV antigen and the incapacity of performing other assays with higher sensitivity, as well as the mismatch between the B/Yamagata lineage circulating strain and the assay strain in one of the study seasons.
目前,两种乙型流感病毒谱系同时流行,具有不同的抗原性,分别命名为维多利亚谱系(Victoria)和山形谱系(Yamagata),以分别指代 B/Victoria/2/87 和 B/Yamagata/16/88 株。我们分析了 2009-2014 年在香港进行的一项基于社区的纵向队列研究中,经 PCR 确诊的乙型流感病毒感染后抗体滴度的动态变化,以评估每种谱系感染后 B/Victoria 和 B/Yamagata 病毒抗体滴度变化的模式。在 62 例经 PCR 确诊的病例中,近一半的病例在感染前和感染后对感染谱系的血凝抑制(HAI)抗体滴度均无法检测到。在感染乙型流感病毒 Victoria 谱系的患者中,我们发现感染后出现了强烈的针对感染谱系的 HAI 滴度反应,同时出现了阳性但较小的交叉谱系 HAI 滴度增强,HAI 滴度增强与感染前滴度的依赖性较小,以及成人 HAI 滴度的半衰期较短。我们的研究受到非乙醚处理的 IBV 抗原的 HAI 敏感性低以及无法进行其他具有更高敏感性的检测的限制,以及在一个研究季节中,B/Yamagata 谱系循环株与检测株不匹配的限制。